Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus bupivacaine for postoperative pain after elective laparotomy wound infiltration
PACTR202407493293626Recruiting
- Sponsor
- Oyeyemi E. Dada, MD, PC
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of ropivacaine and bupivacaine in postoperative pain (2 arms), sponsored by Oyeyemi E. Dada, MD, PC. Primary endpoint: Postoperative pain control efficacy. Started Jul 2024; status: recruiting.
02
Drugs
ropivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202407493293626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407493293626.